HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.
2nd Edition of International Heart Congress
June 20-22,2024 | Hybrid Event
Clinical and Experimental Cardiology
Clinical and Experimental Cardiology
Clinical and experimental cardiology is a scientific discipline concerned with the diagnosis and treatment of cardiac disease. It entails the research and development of new cardiac findings. It includes the clinical state of connected issues, such as their symptoms, diagnosis, treatment, and cure.
Committee Members
Michael E Merhige
State University of NY at Buffalo, United States
Gustavo Knop
Mayo Clinic, United States
Timothy F Christian
Albert Einstein College of Medicine, United States Heart Congress 2024 Speakers
Roger H Coletti
Interventional Health, PA, United States
Pedro A Jose
The George Washington University of School of Medicine & Health Sciences, United States
Yong Xiao Wang
Albany Medical Center, United States
Miroslav Radenkovic
University of Belgrade, SerbiaSubmit your abstract Today
Title : Managing total chronic coronary occlusion: Noninvasive External Counterpulsation (ECP) induces collaterogenesis, relieving ischemia, as demonstrated by quantitative PET myocardial perfusion imaging: ECP is a cost-effective alternative to high risk PCI
Michael E Merhige, State University of NY at Buffalo, United States
Title : Effects of impaired microcirculation in the musculoskeletal system
Roger H Coletti, Interventional Health, PA, United States
Title : Dopamine D2 receptor and inverse salt sensitivity
Pedro A Jose, The George Washington University of School of Medicine & Health Sciences, United States
Title : Novel signaling pathways and therapeutic options for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : Precision medicine for a personalized care in dyslipidaemia
Syed Raza, Awali Hospital, Bahrain
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to be set up through biodesign-inspired and biotech-driven translational applications and cardiology-related marketing to secure the human healthcare and biosafety
Sergey Suchkov, Institute for Biotech & Global Health of RosBiotech and A.I. Evdokimov MGMSU, Russian Federation